A randomized, double-blind, placebo-controlled, crossover human study to evaluate blood alcohol metabolism following Amino Acid Compounds intake

Clinical Study on the Hangover Relief of Amino Acid Compounds

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CRIS

Registry ID

KCT0010612

Enrollment

Registered

2025-06-10

Start date

2024-09-01

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : - The study was conducted according to the following schedule: a vital signs examination (performed 7 days before the main trial) and the main trial. Since this is a crossover stu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy Korean adults (male and female) between the ages of 19 and 49 years

Exclusion criteria

Exclusion criteria: Exclusion Criteria - Individuals who have engaged in excessive alcohol consumption during the past week. - Individuals who have participated in a human application (clinical) study within the past month. - Individuals taking dietary supplements or medications that may affect alcohol metabolism. - Individuals with alcohol metabolism disorders, diabetes, hypertension, gallstones, pancreatitis, gout, active tuberculosis. - Individuals with gastrointestinal bleeding or a history of surgery, or with kidney, liver (e.g., hepatitis B or C carriers, alcoholic liver disease), heart, lung, gastrointestinal, or neurological disorders. - Pregnant or lactating women. - Individuals who usually consume little to no alcohol (less than once a month) or who are abstinent.

Design outcomes

Primary

Measure	Time frame
blood alcohol concentrations and acetaldehyde levels	—

Secondary

Measure	Time frame
Alcohol Hangover Severity Scale (AHSS)	—

Countries

Korea, Republic of

Contacts

Public ContactEUN YOUNG JUNG

Jeonju University

jjjj@jj.ac.kr+82-63-220-2827

Outcome results